The open-source database platform developer will raise $160m if it floats at the top of its range, with Intel, Dell, Red Hat and Salesforce set to exit.

The Pfizer and Ipsen-backed metabolic disorder drug developer floated above its range and saw its share price rise more than 75% on its first day of trading.

The Japan-based mobile accounting software provider has floated in an offering that valued it at more than $500m, giving exits to a host of corporate investors.

The network cybersecurity software provider, valued at $1bn as of 2015, has filed for a $100m IPO that will allow Intel Capital and Itochu to exit.

The underwriters for the corporate-backed television subscription platform's IPO have fully exercised the over-allotment option.

Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.

The streaming device and subscription service has priced an initial public offering in which Sky Ventures will sell more than $9m of shares.

Konica Minolta, Flextronics and NTT Docomo-backed security robot manufacturer Knightscope has secured more than $15.9m in a mini-IPO that has a $20m target.

The online video streaming platform, in which Baidu holds a majority stake, is mulling an early 2018 flotation in the US that could value it at up to $10bn.

The database software supplier, which has raised more than $310m from investors including Salesforce, Intel, EMC, Dell and Red Hat, has filed to go public.